Who bills the most Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (J0717) to Medicare in New Jersey?

19 physician groups billed Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (J0717) to Medicare fee-for-service in New Jersey in 2024; the top five named groups hold 65% of that volume, and independent (non-hospital-affiliated) groups deliver 0%.

J0717 — Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.

Snapshot covers the whole New Jersey market — the table below shows the top 100 groups (free tier).

*Share of New Jersey's disclosed Medicare-FFS services for J0717, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing J0717 in New Jersey — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.